Ross T. Campbell

3.4k total citations · 1 hit paper
70 papers, 1.6k citations indexed

About

Ross T. Campbell is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Ross T. Campbell has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Ross T. Campbell's work include Heart Failure Treatment and Management (34 papers), Cardiovascular Function and Risk Factors (20 papers) and Cardiac pacing and defibrillation studies (11 papers). Ross T. Campbell is often cited by papers focused on Heart Failure Treatment and Management (34 papers), Cardiovascular Function and Risk Factors (20 papers) and Cardiac pacing and defibrillation studies (11 papers). Ross T. Campbell collaborates with scholars based in United Kingdom, United States and Denmark. Ross T. Campbell's co-authors include John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Elke Platz, Allison A. Merz, Ali Vazir, Kieran F. Docherty, Leong Lee, Houman Ashrafian and Michaela Scheuermann‐Freestone and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Ross T. Campbell

63 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

2021 155 citations Colin Berry, Pardeep S. Jhund et al. profile →

Peers

Countries citing papers authored by Ross T. Campbell

Since Specialization

Citations

This map shows the geographic impact of Ross T. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross T. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross T. Campbell more than expected).

Fields of papers citing papers by Ross T. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross T. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross T. Campbell. The network helps show where Ross T. Campbell may publish in the future.

Co-authorship network of co-authors of Ross T. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Ross T. Campbell. A scholar is included among the top collaborators of Ross T. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross T. Campbell. Ross T. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Environmental Chemical Pollutants on Microbiome Diversity: Insights from Shotgun Metagenomics 2025 ·Toxics ·Seid Muhie, Aarti Gautam, John E. Mylroie, (unknown), Ross T. Campbell, (unknown), Rasha Hammamieh, (unknown)	1
2	Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure 2025 ·European Heart Journal ·Kieran F. Docherty, (unknown), Antoni Bayés‐Genís, Ross T. Campbell, Alasdair Henderson, Pardeep S. Jhund, Lars Køber, Morten Schou, Scott D. Solomon, Muthiah Vaduganathan, Jil Mamza, Christopher Ll. Morgan, (unknown), Ruiqi Zhang, Mark C Petrie, John J.V. McMurray	1
3	Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2024 ·European Heart Journal ·(unknown), (unknown), Colin Berry, Ross T. Campbell, Kieran F. Docherty, John Dreisbach, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Joanna Osmanska, Giles Roditi, Mark C. Petrie, (unknown), Matthew M.Y. Lee	2
4	Bone loss with aging is independent of gut microbiome in mice 2024 ·Bone Research ·Xiaomeng You, Jing Yan, Jeremy Herzog, (unknown), Ross T. Campbell, Allison Hoke, Rasha Hammamieh, R. Balfour Sartor, Sandra J. Shefelbine, Melissa A. Kacena, Nabarun Chakraborty, Julia F. Charles	1
5	Ionizing Radiation Dose Differentially Affects the Host–Microbe Relationship over Time 2024 ·Microorganisms ·Nabarun Chakraborty, Allison Hoke, Ross T. Campbell, Gregory P. Holmes‐Hampton, Vidya P. Kumar, (unknown), Aarti Gautam, Rasha Hammamieh, Sanchita Ghosh	1
6	Subcutaneous furosemide in heart failure: a systematic review 2024 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Joanna Osmanska, Mark C. Petrie, Kieran F. Docherty, Matthew M.Y. Lee, John J.V. McMurray, Ross T. Campbell	2
7	Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2023 ·European Heart Journal ·Matthew M.Y. Lee, Paul Welsh, Colin Berry, Katriona Brooksbank, Ross T. Campbell, Kieran F. Docherty, Joanna Osmanska, Giles Roditi, Kirsty Wetherall, Alex McConnachie, Patrick B. Mark, John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Naveed Sattar	0
8	A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Joanna Osmanska, Katriona Brooksbank, Kieran F. Docherty, (unknown), Kirsty Wetherall, Alex McConnachie, Jerry C. Hu, Roy S. Gardner, Andrew L. Clark, Iain Squire, Paul R. Kalra, Pardeep S. Jhund, Pieter Muntendam, John J.V. McMurray, Mark C. Petrie, Ross T. Campbell	5
9	Neuropeptide Y is Elevated in Heart Failure and is an Independent Predictor of Outcomes 2023 ·European Journal of Heart Failure ·(unknown), Carly Adamson, Colette E. Jackson, Ross T. Campbell, Paul Welsh, Mark C. Petrie, John J.V. McMurray, Pardeep S. Jhund, Neil Herring	16
10	Biomarker discovery process at binomial decision point (2BDP): Analytical pipeline to construct biomarker panel 2023 ·Computational and Structural Biotechnology Journal ·Nabarun Chakraborty, (unknown), Ross T. Campbell, Ruoting Yang, Rasha Hammamieh	1
11	Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF 2023 ·Circulation ·Su Ern Yeoh, Kieran F. Docherty, Ross T. Campbell, Pardeep S. Jhund, Ann Hammarstedt, Hiddo J.L. Heerspink, Petr Jarolı́m, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Scott D. Solomon, Mikaela Sjöstrand, Olof Bengtsson, Peter J. Greasley, Naveed Sattar, Paul Welsh, Marc S. Sabatine, David A. Morrow, John J.V. McMurray	24
12	Defining Heart Failure Based on Imaging the Heart and Beyond 2023 ·Cardiac failure review ·Fraser J Graham, (unknown), (unknown), Ross T. Campbell, (unknown), John G.F. Cleland, Pierpaolo Pellicori	1
13	Sex Differences in Congestive Markers in Patients Hospitalized for Acute Heart Failure 2021 ·ESC Heart Failure ·(unknown), Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, John D. Groarke, Kieran F. Docherty, Matthew M.Y. Lee, (unknown), Tor Biering‐Sørensen, Scott D. Solomon, John J.V. McMurray, Elke Platz	8
14	Which Patients with Heart Failure Should Receive Specialist Palliative Care? 2018 ·European Journal of Heart Failure ·Ross T. Campbell, Mark C. Petrie, Colette E. Jackson, Pardeep S. Jhund, Ann Wright, Roy S. Gardner, (unknown), Andrea Pozzi, Paula McSkimming, Alex McConnachie, Fiona Finlay, Patricia M. Davidson, Martin A. Denvir, Miriam J. Johnson, Karen Hogg, John J.V. McMurray	56
15	Redefining Heart Failure Phenotypes Based on Ejection Fraction 2018 ·European Journal of Heart Failure ·Ross T. Campbell, Mark C. Petrie, John J.V. McMurray	4
16	Dynamic Changes and Prognostic Value of Pulmonary Congestion by Lung Ultrasound in Acute and Chronic Heart Failure: A Systematic Review 2017 ·European Journal of Heart Failure ·Elke Platz, Allison A. Merz, Pardeep S. Jhund, Ali Vazir, Ross T. Campbell, John J.V. McMurray	165
17	Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis: A Network Meta-Analysis 2017 ·Value in Health ·Jean‐Yves Reginster, F. Bianic, Ross T. Campbell, Michael Martin, Setareh A. Williams, Lorraine A. Fitzpatrick	4
18	Assessment and Prevalence of Pulmonary Oedema in Contemporary Acute Heart Failure Trials: A Systematic Review 2015 ·European Journal of Heart Failure ·Elke Platz, Pardeep S. Jhund, Ross T. Campbell, John J.V. McMurray	47
19	What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE? 2012 ·Journal of the American College of Cardiology ·Ross T. Campbell, Pardeep S. Jhund, Davide Castagno, Nathaniel M. Hawkins, Mark C. Petrie, John J.V. McMurray	131
20	Nitric oxide does not significantly contribute to altered pulse pressure amplification during aerobic exercise 2006 ·Journal of Molecular and Cellular Cardiology ·James E. Sharman, C.M. McEniery, Ross T. Campbell, Pawan Pusalkar, Ian B. Wilkinson, Jeff S. Coombes, John R. Cockcroft	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact